Cargando…
Clarification of Dalfampridine Labeled Indications
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437778/ https://www.ncbi.nlm.nih.gov/pubmed/22380474 http://dx.doi.org/10.18553/jmcp.2012.18.2.156 |
| _version_ | 1785092611625713664 |
|---|---|
| author | Rabinowicz, Adrian L. Carrazana, Enrique J. |
| author_facet | Rabinowicz, Adrian L. Carrazana, Enrique J. |
| author_sort | Rabinowicz, Adrian L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10437778 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104377782023-08-21 Clarification of Dalfampridine Labeled Indications Rabinowicz, Adrian L. Carrazana, Enrique J. J Manag Care Pharm Letters Academy of Managed Care Pharmacy 2012-03 /pmc/articles/PMC10437778/ /pubmed/22380474 http://dx.doi.org/10.18553/jmcp.2012.18.2.156 Text en Copyright © 2012, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Letters Rabinowicz, Adrian L. Carrazana, Enrique J. Clarification of Dalfampridine Labeled Indications |
| title | Clarification of Dalfampridine Labeled Indications |
| title_full | Clarification of Dalfampridine Labeled Indications |
| title_fullStr | Clarification of Dalfampridine Labeled Indications |
| title_full_unstemmed | Clarification of Dalfampridine Labeled Indications |
| title_short | Clarification of Dalfampridine Labeled Indications |
| title_sort | clarification of dalfampridine labeled indications |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437778/ https://www.ncbi.nlm.nih.gov/pubmed/22380474 http://dx.doi.org/10.18553/jmcp.2012.18.2.156 |
| work_keys_str_mv | AT rabinowiczadrianl clarificationofdalfampridinelabeledindications AT carrazanaenriquej clarificationofdalfampridinelabeledindications |